Diazepam is NOT recommended for insomnia treatment
Diazepam should not be used as a sleep aid. The FDA-approved indications for diazepam do not include insomnia, and current clinical practice guidelines explicitly recommend against using benzodiazepines like diazepam for sleep induction 1, 2.
Why Diazepam Should Be Avoided for Sleep
The 2017 American Academy of Sleep Medicine guideline specifically addresses chronic insomnia pharmacotherapy and notably does not recommend diazepam for this indication 1. While the guideline suggests other benzodiazepines like triazolam (0.25 mg) and temazepam (15 mg) for specific insomnia subtypes, diazepam is conspicuously absent from their recommendations.
The 2016 American College of Physicians guideline similarly emphasizes cognitive behavioral therapy as first-line treatment and, when discussing pharmacotherapy, focuses on newer agents rather than older benzodiazepines like diazepam 2.
FDA-Approved Dosing (Not for Insomnia)
According to the FDA label, diazepam's approved indications and dosing are 3:
- Anxiety disorders: 2-10 mg, 2-4 times daily
- Acute alcohol withdrawal: 10 mg, 3-4 times in first 24 hours
- Skeletal muscle spasm: 2-10 mg, 3-4 times daily
- Geriatric/debilitated patients: 2-2.5 mg, 1-2 times daily initially
Sleep induction is not an FDA-approved indication.
Critical Safety Concerns
The FDA label warns of serious risks that make diazepam particularly problematic for sleep use 3:
- Respiratory depression, especially when combined with opioids or alcohol
- "Sleep driving" and behavioral abnormalities
- Physical dependence and withdrawal reactions with prolonged use
- Daytime impairment affecting driving and machinery operation
- Increased risk of dementia, serious injury, and fractures in observational studies 2
What the Research Actually Shows
While older studies from the 1970s examined diazepam's effects on sleep at doses of 5-15 mg 4, 5, 6, these were short-term experimental studies in healthy volunteers—not clinical recommendations for insomnia treatment. The research showed that diazepam's effects were less pronounced in middle-aged adults compared to younger subjects 5, and modern guidelines have moved away from recommending this approach entirely.
Recommended Alternatives
For sleep induction in adults, current guidelines suggest 1:
- First-line: Cognitive behavioral therapy for insomnia (CBT-I)
- Pharmacotherapy options (if CBT-I unsuccessful):
- Eszopiclone (2-3 mg)
- Zolpidem (10 mg)
- Zaleplon (10 mg) for sleep onset
- Temazepam (15 mg)
- Doxepin (3-6 mg) for sleep maintenance
- Suvorexant (10-20 mg)
Common Pitfall to Avoid
Do not prescribe diazepam off-label for insomnia simply because it causes sedation. The long half-life of diazepam (20-100 hours) and its active metabolite desmethyldiazepam leads to accumulation, next-day impairment, and increased fall risk—particularly problematic in elderly patients 3. The risk-benefit ratio strongly favors either non-pharmacological approaches or FDA-approved hypnotics specifically studied for insomnia.